{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:36:16Z","timestamp":1790361376557,"version":"4.1.0"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02988-8","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:43:54Z","timestamp":1757162634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The microbiome\u2013cancer axis as a hidden contributor to early-onset tumorigenesis"],"prefix":"10.1007","volume":"42","author":[{"given":"Azfar","family":"Jamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Azhar","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser E.","family":"Alqurashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esam S.","family":"Al-Malki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Naiyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Arif","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroonrashid M.","family":"Hattiwale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,6]]},"reference":[{"key":"2988_CR1","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1158\/2159-8290.CD-22-1038","volume":"13","author":"I Ben-Aharon","year":"2023","unstructured":"Ben-Aharon I, van Laarhoven HWM, Fontana E, Obermannova R, Nilsson M, Lordick F. Early-onset cancer in the gastrointestinal tract is on the rise-evidence and implications. Cancer Discov. 2023;13:538\u201351. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-1038.","journal-title":"Cancer Discov"},{"key":"2988_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2023-000049","volume":"2","author":"J Zhao","year":"2023","unstructured":"Zhao J, Xu L, Sun J, Song M, Wang L, Yuan S, et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. Bmjonc. 2023;2:e000049. https:\/\/doi.org\/10.1136\/bmjonc-2023-000049.","journal-title":"Bmjonc"},{"key":"2988_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20407","volume":"3","author":"WH Abualkhair","year":"2020","unstructured":"Abualkhair WH, Zhou M, Ahnen D, Yu Q, Wu X-C, Karlitz JJ. Trends in incidence of early-onset colorectal cancer in the United States among those approaching screening age. JAMA Netw Open. 2020;3:e1920407. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.20407.","journal-title":"JAMA Netw Open"},{"key":"2988_CR4","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1158\/1538-7445.AM2024-4847","volume":"84","author":"M Terashima","year":"2024","unstructured":"Terashima M, Lee H-Y, Tsukumo Y, Ugai S, Song M, Sasamoto N, et al. Abstract 4847: diverging global incidence trends of early-onset and later-onset cancers. Cancer Res. 2024;84:4847\u20134847. https:\/\/doi.org\/10.1158\/1538-7445.AM2024-4847.","journal-title":"Cancer Res"},{"key":"2988_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30411-4","volume":"18","author":"J Kerr","year":"2017","unstructured":"Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol. 2017;18:e457\u201371. https:\/\/doi.org\/10.1016\/S1470-2045(17)30411-4.","journal-title":"Lancet Oncol"},{"key":"2988_CR6","doi-asserted-by":"publisher","unstructured":"Marcus PM. Population measures: cancer screening\u2019s impact. Assessment of cancer screening: A primer, Cham: Springer International Publishing; 2022, p. 51\u201366. https:\/\/doi.org\/10.1007\/978-3-030-94577-0_5.","DOI":"10.1007\/978-3-030-94577-0_5"},{"key":"2988_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101737","volume":"5","author":"G Mauri","year":"2024","unstructured":"Mauri G, Patelli G, Sartore-Bianchi A, Abrignani S, Bodega B, Marsoni S, et al. Early-onset cancers: biological bases and clinical implications. Cell Rep Med. 2024;5:101737. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101737.","journal-title":"Cell Rep Med"},{"key":"2988_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf050","author":"L Owens","year":"2025","unstructured":"Owens L, Fung A, Shuhendler J, Glick J, Ryser MD, Gulati R, et al. Trends in young-onset cancer incidence: a modeling perspective. J Natl Cancer Inst. 2025. https:\/\/doi.org\/10.1093\/jnci\/djaf050.","journal-title":"J Natl Cancer Inst"},{"key":"2988_CR9","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","volume":"19","author":"T Ugai","year":"2022","unstructured":"Ugai T, Sasamoto N, Lee H-Y, Ando M, Song M, Tamimi RM, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022;19:656\u201373. https:\/\/doi.org\/10.1038\/s41571-022-00672-8.","journal-title":"Nat Rev Clin Oncol"},{"key":"2988_CR10","doi-asserted-by":"publisher","first-page":"2269623","DOI":"10.1080\/19490976.2023.2269623","volume":"15","author":"K Mima","year":"2023","unstructured":"Mima K, Hamada T, Inamura K, Baba H, Ugai T, Ogino S. The microbiome and rise of early-onset cancers: knowledge gaps and research opportunities. Gut Microbes. 2023;15:2269623. https:\/\/doi.org\/10.1080\/19490976.2023.2269623.","journal-title":"Gut Microbes"},{"key":"2988_CR11","doi-asserted-by":"publisher","first-page":"1370108","DOI":"10.3389\/fpubh.2024.1370108","volume":"12","author":"AM Atchade","year":"2024","unstructured":"Atchade AM, Williams JL, Mermelstein L, Nemesure B. Unraveling the complexities of early-onset colorectal cancer: a perspective on dietary and microbial influences. Front Public Health. 2024;12:1370108. https:\/\/doi.org\/10.3389\/fpubh.2024.1370108.","journal-title":"Front Public Health"},{"key":"2988_CR12","doi-asserted-by":"publisher","first-page":"e0015123","DOI":"10.1128\/msystems.00151-23","volume":"8","author":"SB Busi","year":"2023","unstructured":"Busi SB, Lei Z, Sumner LW, Amos-Landgraf JM. Integrated multi-omic analyses provide insight into colon adenoma susceptibility modulation by the gut microbiota. mSystems. 2023;8:e0015123. https:\/\/doi.org\/10.1128\/msystems.00151-23.","journal-title":"mSystems"},{"key":"2988_CR13","doi-asserted-by":"publisher","first-page":"612202","DOI":"10.3389\/fimmu.2020.612202","volume":"11","author":"Q Qiu","year":"2020","unstructured":"Qiu Q, Lin Y, Ma Y, Li X, Liang J, Chen Z, et al. Exploring the emerging role of the gut microbiota and tumor microenvironment in cancer immunotherapy. Front Immunol. 2020;11:612202. https:\/\/doi.org\/10.3389\/fimmu.2020.612202.","journal-title":"Front Immunol"},{"key":"2988_CR14","doi-asserted-by":"publisher","first-page":"1008975","DOI":"10.3389\/fimmu.2022.1008975","volume":"13","author":"Z Xu","year":"2022","unstructured":"Xu Z, Lv Z, Chen F, Zhang Y, Xu Z, Huo J, et al. Dysbiosis of human tumor microbiome and aberrant residence of Actinomyces in tumor-associated fibroblasts in young-onset colorectal cancer. Front Immunol. 2022;13:1008975. https:\/\/doi.org\/10.3389\/fimmu.2022.1008975.","journal-title":"Front Immunol"},{"key":"2988_CR15","doi-asserted-by":"publisher","unstructured":"Roelands J, Ploeg M van der, Dang H, Hawinkels L, Morreau H, Miranda N de. 673\u2005(Re-) Solving the biology of colorectal cancer onset and progression to improve treatment and prevention. Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd; 2021, p. A701\u2013A701. https:\/\/doi.org\/10.1136\/jitc-2021-SITC2021.673.","DOI":"10.1136\/jitc-2021-SITC2021.673"},{"key":"2988_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107321","volume":"207","author":"C Cao","year":"2024","unstructured":"Cao C, Yue S, Lu A, Liang C. Host-gut microbiota metabolic interactions and their role in precision diagnosis and treatment of gastrointestinal cancers. Pharmacol Res. 2024;207:107321. https:\/\/doi.org\/10.1016\/j.phrs.2024.107321.","journal-title":"Pharmacol Res"},{"key":"2988_CR17","doi-asserted-by":"publisher","unstructured":"M.Phil Health Biotechnology, Department of Biotechnology, Faculty of Chemical and Life Sciences Abdul Wali Khan University Mardan, Pakistan, Nouman M, Humayun F, Department of Biotechnology, Abdul Wali Khan University Mardan, Pakistan, khan SA, Department: Biotechnology and Genetic Engineering, Hazara University Mansehra, Pakistan, et al. Gut Microbiome-Host microRNA Interactions in Cancer Development and Immune Regulation: A Case of Colorectal and Breast Cancer. TAJMSPR 2025;7:6\u201320. https:\/\/doi.org\/10.37547\/tajmspr\/Volume07Issue02-02.","DOI":"10.37547\/tajmspr\/Volume07Issue02-02"},{"key":"2988_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/path.5236","volume":"247","author":"T Hamada","year":"2019","unstructured":"Hamada T, Nowak JA, Milner DA, Song M, Ogino S. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms. J Pathol. 2019;247:615\u201328. https:\/\/doi.org\/10.1002\/path.5236.","journal-title":"J Pathol"},{"key":"2988_CR19","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1200\/JCO.2024.42.16_suppl.4016","volume":"42","author":"T Jayakrishnan","year":"2024","unstructured":"Jayakrishnan T, Sangwan N, Nair KG, Kamath SD, Patel M, Joyce D, et al. Tumor microbiome differences in early-onset versus average-onset pancreatic adenocarcinoma. JCO. 2024;42:4016\u20134016. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.4016.","journal-title":"JCO"},{"key":"2988_CR20","doi-asserted-by":"publisher","first-page":"1020583","DOI":"10.3389\/fcimb.2022.1020583","volume":"12","author":"S Ou","year":"2022","unstructured":"Ou S, Wang H, Tao Y, Luo K, Ye J, Ran S, et al. Fusobacterium nucleatum and colorectal cancer: from phenomenon to mechanism. Front Cell Infect Microbiol. 2022;12:1020583. https:\/\/doi.org\/10.3389\/fcimb.2022.1020583.","journal-title":"Front Cell Infect Microbiol"},{"key":"2988_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4552","author":"GD Sepich-Poore","year":"2021","unstructured":"Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The microbiome and human cancer. Science. 2021. https:\/\/doi.org\/10.1126\/science.abc4552.","journal-title":"Science"},{"key":"2988_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1158\/1940-6207.CAPR-23-0091","volume":"17","author":"D Adnan","year":"2024","unstructured":"Adnan D, Trinh JQ, Sharma D, Alsayid M, Bishehsari F. Early-onset colon cancer shows a distinct intestinal microbiome and a host-microbe interaction. Cancer Prev Res (Phila Pa). 2024;17:29\u201338. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-23-0091.","journal-title":"Cancer Prev Res (Phila Pa)"},{"key":"2988_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12967-022-03492-7","volume":"20","author":"H Sadrekarimi","year":"2022","unstructured":"Sadrekarimi H, Gardanova ZR, Bakhshesh M, Ebrahimzadeh F, Yaseri AF, Thangavelu L, et al. Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora. J Transl Med. 2022;20:301. https:\/\/doi.org\/10.1186\/s12967-022-03492-7.","journal-title":"J Transl Med"},{"key":"2988_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/PSY.0000000000000470","volume":"79","author":"J Sundin","year":"2017","unstructured":"Sundin J, \u00d6hman L, Simr\u00e9n M. Understanding the gut microbiota in inflammatory and functional gastrointestinal diseases. Psychosom Med. 2017;79:857\u201367. https:\/\/doi.org\/10.1097\/PSY.0000000000000470.","journal-title":"Psychosom Med"},{"issue":"1","key":"2988_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.69750\/dmls.02.01.089","volume":"2","author":"M Tariq","year":"2025","unstructured":"Tariq M, Gulzar M, Mir D, Kousar M. The role of the gut microbiome in immune dysregulation and pathogenesis of inflammatory bowel disease: microbial dysbiosis in inflammatory bowel disease. Dev Medico-Life-Sci. 2025;2(1):13\u201325.","journal-title":"Dev Medico-Life-Sci."},{"key":"2988_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13073-016-0331-y","volume":"8","author":"KA Shaw","year":"2016","unstructured":"Shaw KA, Bertha M, Hofmekler T, Chopra P, Vatanen T, Srivatsa A, et al. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease. Genome Med. 2016;8:75. https:\/\/doi.org\/10.1186\/s13073-016-0331-y.","journal-title":"Genome Med"},{"key":"2988_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s40168-018-0603-4","volume":"6","author":"JD Forbes","year":"2018","unstructured":"Forbes JD, Chen C-Y, Knox NC, Marrie R-A, El-Gabalawy H, de Kievit T, et al. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? Microbiome. 2018;6:221. https:\/\/doi.org\/10.1186\/s40168-018-0603-4.","journal-title":"Microbiome"},{"issue":"2","key":"2988_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.chom.2017.01.005","volume":"21","author":"ER Hughes","year":"2017","unstructured":"Hughes ER, Winter MG, Duerkop BA, Spiga L, de Carvalho TF, Zhu W, et al. Microbial respiration and formate oxidation as metabolic signatures of inflammation-associated Dysbiosis. Cell Host Microbe. 2017;21(2):208\u201319. https:\/\/doi.org\/10.1016\/j.chom.2017.01.005.","journal-title":"Cell Host Microbe"},{"key":"2988_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113839","author":"M Potrykus","year":"2021","unstructured":"Potrykus M, Czaja-Stolc S, Stankiewicz M, Kaska \u0141, Ma\u0142gorzewicz S. Intestinal microbiota as a contributor to chronic inflammation and its potential modifications. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13113839.","journal-title":"Nutrients"},{"key":"2988_CR30","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3390\/ijms26041773","volume":"26","author":"E Pe\u00f1a-Dur\u00e1n","year":"2025","unstructured":"Pe\u00f1a-Dur\u00e1n E, Garc\u00eda-Galindo JJ, L\u00f3pez-Murillo LD, Huerta-Huerta A, Balleza-Alejandri LR, Beltr\u00e1n-Ram\u00edrez A, et al. Microbiota and inflammatory markers: a review of their interplay, clinical implications, and metabolic disorders. Ijms. 2025;26:1773. https:\/\/doi.org\/10.3390\/ijms26041773.","journal-title":"Ijms"},{"key":"2988_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2022.135320","volume":"410","author":"F Ahmad","year":"2023","unstructured":"Ahmad F, Saha P, Singh V, Wahid M, Mandal RK, Nath Mishra B, et al. Diet as a modifiable factor in tumorigenesis: focus on microbiome-derived bile acid metabolites and short-chain fatty acids. Food Chem. 2023;410:135320. https:\/\/doi.org\/10.1016\/j.foodchem.2022.135320.","journal-title":"Food Chem"},{"key":"2988_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111572","volume":"546","author":"KJ O\u2019Riordan","year":"2022","unstructured":"O\u2019Riordan KJ, Collins MK, Moloney GM, Knox EG, Aburto MR, F\u00fclling C, et al. Short chain fatty acids: microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol. 2022;546:111572. https:\/\/doi.org\/10.1016\/j.mce.2022.111572.","journal-title":"Mol Cell Endocrinol"},{"key":"2988_CR33","doi-asserted-by":"publisher","unstructured":"Filatov MS, Dovgan RS, Makarenko OM. Microbiome changes under bile tract obstruction due to progressive growth of pancreas tumour. Act Probl of the Modern Med 2018;18:137\u201341. https:\/\/doi.org\/10.31718\/2077-1096.18.4.137.","DOI":"10.31718\/2077-1096.18.4.137"},{"key":"2988_CR34","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1091\/mbc.e03-12-0894","volume":"15","author":"R Pai","year":"2004","unstructured":"Pai R, Tarnawski AS, Tran T. Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol Biol Cell. 2004;15:2156\u201363. https:\/\/doi.org\/10.1091\/mbc.e03-12-0894.","journal-title":"Mol Biol Cell"},{"key":"2988_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/biom15020270","author":"AN Mafe","year":"2025","unstructured":"Mafe AN, B\u00fcsselberg D. Modulation of the neuro-cancer connection by metabolites of gut microbiota. Biomolecules. 2025. https:\/\/doi.org\/10.3390\/biom15020270.","journal-title":"Biomolecules"},{"key":"2988_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117031","volume":"177","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang Y, Jin S, Lv J, Li M, Feng N. The gut microbiota derived metabolite trimethylamine N-oxide: its important role in cancer and other diseases. Biomed Pharmacother. 2024;177:117031. https:\/\/doi.org\/10.1016\/j.biopha.2024.117031.","journal-title":"Biomed Pharmacother"},{"key":"2988_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13071114","author":"S Waldstein","year":"2023","unstructured":"Waldstein S, Spengler M, Pinchuk IV, Yee NS. Impact of colorectal cancer sidedness and location on therapy and clinical outcomes: role of blood-based biopsy for personalized treatment. J Pers Med. 2023. https:\/\/doi.org\/10.3390\/jpm13071114.","journal-title":"J Pers Med"},{"key":"2988_CR38","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/ecco-jcc\/jjae061","volume":"18","author":"DA Mu\u00f1iz Pedrogo","year":"2024","unstructured":"Mu\u00f1iz Pedrogo DA, Sears CL, Melia JMP. Colorectal cancer in inflammatory bowel disease: a review of the role of gut microbiota and bacterial biofilms in disease pathogenesis. J Crohns Colitis. 2024;18:1713\u201325. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae061.","journal-title":"J Crohns Colitis"},{"key":"2988_CR39","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s12602-022-09967-9","volume":"14","author":"T Wang","year":"2022","unstructured":"Wang T, Zheng J, Dong S, Ismael M, Shan Y, Wang X, et al. Lacticaseibacillus rhamnosus LS8 ameliorates azoxymethane\/dextran sulfate sodium-induced colitis-associated tumorigenesis in mice via regulating gut microbiota and inhibiting inflammation. Probiotics Antimicrob Proteins. 2022;14:947\u201359. https:\/\/doi.org\/10.1007\/s12602-022-09967-9.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"2988_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12929-025-01117-x","volume":"32","author":"N Wang","year":"2025","unstructured":"Wang N, Wu S, Huang L, Hu Y, He X, He J, et al. Intratumoral microbiome: implications for immune modulation and innovative therapeutic strategies in cancer. J Biomed Sci. 2025;32:23. https:\/\/doi.org\/10.1186\/s12929-025-01117-x.","journal-title":"J Biomed Sci"},{"key":"2988_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.03.035","volume":"31","author":"AI Yu","year":"2020","unstructured":"Yu AI, Zhao L, Eaton KA, Ho S, Chen J, Poe S, et al. Gut microbiota modulate CD8 T cell responses to influence colitis-associated tumorigenesis. Cell Rep. 2020;31:107471. https:\/\/doi.org\/10.1016\/j.celrep.2020.03.035.","journal-title":"Cell Rep"},{"key":"2988_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104163","volume":"82","author":"X Li","year":"2022","unstructured":"Li X, Zhang S, Guo G, Han J, Yu J. Gut microbiome in modulating immune checkpoint inhibitors. EBioMedicine. 2022;82:104163. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104163.","journal-title":"EBioMedicine"},{"key":"2988_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11010107","author":"N Nikolaieva","year":"2022","unstructured":"Nikolaieva N, Sevcikova A, Omelka R, Martiniakova M, Mego M, Ciernikova S. Gut microbiota-MicroRNA interactions in intestinal homeostasis and cancer development. Microorganisms. 2022. https:\/\/doi.org\/10.3390\/microorganisms11010107.","journal-title":"Microorganisms"},{"key":"2988_CR44","doi-asserted-by":"publisher","DOI":"10.5402\/2011\/869647","volume":"2011","author":"PV Licciardi","year":"2011","unstructured":"Licciardi PV, Ververis K, Karagiannis TC. Histone deacetylase inhibition and dietary short-chain Fatty acids. ISRN Allergy. 2011;2011:869647. https:\/\/doi.org\/10.5402\/2011\/869647.","journal-title":"ISRN Allergy"},{"key":"2988_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115773","volume":"168","author":"S Qu","year":"2023","unstructured":"Qu S, Gao Y, Ma J, Yan Q. Microbiota-derived short-chain fatty acids functions in the biology of B lymphocytes: from differentiation to antibody formation. Biomed Pharmacother. 2023;168:115773. https:\/\/doi.org\/10.1016\/j.biopha.2023.115773.","journal-title":"Biomed Pharmacother"},{"key":"2988_CR46","doi-asserted-by":"publisher","unstructured":"Kumar A, Ali A, Kapardar RK, Dar GM, Nimisha, Apurva, et al. Implication of gut microbes and its metabolites in colorectal cancer. J Cancer Res Clin Oncol 2023;149:441\u201365. https:\/\/doi.org\/10.1007\/s00432-022-04422-2.","DOI":"10.1007\/s00432-022-04422-2"},{"key":"2988_CR47","doi-asserted-by":"publisher","first-page":"1367818","DOI":"10.3389\/fpubh.2024.1367818","volume":"12","author":"Z Wang","year":"2024","unstructured":"Wang Z, Yao W, Wu W, Huang J, Ma Y, Yang C, et al. Global incidence trends of early-onset colorectal cancer and related exposures in early-life: an ecological analysis based on the GBD 2019. Front Public Health. 2024;12:1367818. https:\/\/doi.org\/10.3389\/fpubh.2024.1367818.","journal-title":"Front Public Health"},{"key":"2988_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.104980","volume":"100","author":"SV Barot","year":"2024","unstructured":"Barot SV, Sangwan N, Nair KG, Schmit SL, Xiang S, Kamath S, et al. Distinct intratumoral microbiome of young-onset and average-onset colorectal cancer. EBioMedicine. 2024;100:104980. https:\/\/doi.org\/10.1016\/j.ebiom.2024.104980.","journal-title":"EBioMedicine"},{"key":"2988_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133509","author":"B Medici","year":"2023","unstructured":"Medici B, Ricc\u00f2 B, Caffari E, Zaniboni S, Salati M, Spallanzani A, et al. Early onset metastatic colorectal cancer: current insights and clinical management of a rising condition. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15133509.","journal-title":"Cancers (Basel)"},{"key":"2988_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123202","author":"F Ullah","year":"2023","unstructured":"Ullah F, Pillai AB, Omar N, Dima D, Harichand S. Early-onset colorectal cancer: current insights. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15123202.","journal-title":"Cancers (Basel)"},{"key":"2988_CR51","doi-asserted-by":"publisher","first-page":"1036946","DOI":"10.3389\/fcimb.2022.1036946","volume":"12","author":"H Xiong","year":"2022","unstructured":"Xiong H, Wang J, Chang Z, Hu H, Yuan Z, Zhu Y, et al. Gut microbiota display alternative profiles in patients with early-onset colorectal cancer. Front Cell Infect Microbiol. 2022;12:1036946. https:\/\/doi.org\/10.3389\/fcimb.2022.1036946.","journal-title":"Front Cell Infect Microbiol"},{"key":"2988_CR52","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1158\/1538-7445.AM2024-2805","volume":"84","author":"M Lumish","year":"2024","unstructured":"Lumish M, Waters N, Leinwand J, Saxena A, Dai A, Fei T, et al. Abstract 2805: Shotgun sequencing of serial fecal microbiome samples in patients with colorectal cancer reveals distinct bacterial species and metabolic pathways associated with tumor sidedness and age at diagnosis. Cancer Res. 2024;84:2805\u20132805. https:\/\/doi.org\/10.1158\/1538-7445.AM2024-2805.","journal-title":"Cancer Res"},{"key":"2988_CR53","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jcmgh.2024.02.009","volume":"17","author":"KA Breau","year":"2024","unstructured":"Breau KA. Actinomyces odontolyticus: From Carries to Colorectal Cancer. Cell Mol Gastroenterol Hepatol. 2024;17:879\u201380. https:\/\/doi.org\/10.1016\/j.jcmgh.2024.02.009.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"5","key":"2988_CR54","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jcmgh.2024.01.010","volume":"17","author":"Y Miyakawa","year":"2024","unstructured":"Miyakawa Y, Otsuka M, Shibata C, Seimiya T, Yamamoto K, Ishibashi R, et al. Gut bacteria-derived membrane vesicles induce colonic dysplasia by inducing DNA damage in colon epithelial cells. Cell Mol Gastroenterol Hepatol. 2024;17(5):745\u201367. https:\/\/doi.org\/10.1016\/j.jcmgh.2024.01.010.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2988_CR55","doi-asserted-by":"publisher","first-page":"1413266","DOI":"10.3389\/fcimb.2024.1413266","volume":"14","author":"L Huang","year":"2024","unstructured":"Huang L, Jiang C, Yan M, Wan W, Li S, Xiang Z, et al. The oral-gut microbiome axis in breast cancer: from basic research to therapeutic applications. Front Cell Infect Microbiol. 2024;14:1413266. https:\/\/doi.org\/10.3389\/fcimb.2024.1413266.","journal-title":"Front Cell Infect Microbiol"},{"key":"2988_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuad039","author":"R Mart\u00edn","year":"2023","unstructured":"Mart\u00edn R, Rios-Covian D, Huillet E, Auger S, Khazaal S, Berm\u00fadez-Humar\u00e1n LG, et al. Faecalibacterium: a bacterial genus with promising human health applications. FEMS Microbiol Rev. 2023. https:\/\/doi.org\/10.1093\/femsre\/fuad039.","journal-title":"FEMS Microbiol Rev"},{"key":"2988_CR57","doi-asserted-by":"publisher","unstructured":"Kwa M, Plottel CS, Blaser MJ, Adams S. The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer. J Natl Cancer Inst 2016;108. https:\/\/doi.org\/10.1093\/jnci\/djw029.","DOI":"10.1093\/jnci\/djw029"},{"key":"2988_CR58","doi-asserted-by":"publisher","first-page":"30751","DOI":"10.1038\/srep30751","volume":"6","author":"TJ Hieken","year":"2016","unstructured":"Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep. 2016;6:30751. https:\/\/doi.org\/10.1038\/srep30751.","journal-title":"Sci Rep"},{"key":"2988_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106916","volume":"196","author":"X Zhao","year":"2023","unstructured":"Zhao X, Zhao J, Li D, Yang H, Chen C, Qin M, et al. Akkermansia muciniphila: a potential target and pending issues for oncotherapy. Pharmacol Res. 2023;196:106916. https:\/\/doi.org\/10.1016\/j.phrs.2023.106916.","journal-title":"Pharmacol Res"},{"key":"2988_CR60","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.jand.2018.08.164","volume":"120","author":"AD Frug\u00e9","year":"2020","unstructured":"Frug\u00e9 AD, Van der Pol W, Rogers LQ, Morrow CD, Tsuruta Y, Demark-Wahnefried W. Fecal Akkermansia muciniphila is associated with body composition and microbiota diversity in overweight and obese women with breast cancer participating in a presurgical weight loss trial. J Acad Nutr Diet. 2020;120:650\u20139. https:\/\/doi.org\/10.1016\/j.jand.2018.08.164.","journal-title":"J Acad Nutr Diet"},{"key":"2988_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107726","volume":"215","author":"M Huang","year":"2025","unstructured":"Huang M, Zhang Y, Chen Z, Yu X, Luo S, Peng X, et al. Gut microbiota reshapes the TNBC immune microenvironment: emerging immunotherapeutic strategies. Pharmacol Res. 2025;215:107726. https:\/\/doi.org\/10.1016\/j.phrs.2025.107726.","journal-title":"Pharmacol Res"},{"key":"2988_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103012","volume":"24","author":"AM McKee","year":"2021","unstructured":"McKee AM, Kirkup BM, Madgwick M, Fowler WJ, Price CA, Dreger SA, et al. Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth. IScience. 2021;24:103012. https:\/\/doi.org\/10.1016\/j.isci.2021.103012.","journal-title":"IScience"},{"key":"2988_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cells12151945","author":"G Bernardo","year":"2023","unstructured":"Bernardo G, Le Noci V, Di Modica M, Montanari E, Triulzi T, Pupa SM, et al. The emerging role of the microbiota in breast cancer progression. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12151945.","journal-title":"Cells"},{"key":"2988_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.604531","volume":"10","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhang K, Zhang P, Zheng J, Min C, Li X. Research progress of pancreas-related microorganisms and pancreatic cancer. Front Oncol. 2020;10:604531. https:\/\/doi.org\/10.3389\/fonc.2020.604531.","journal-title":"Front Oncol"},{"key":"2988_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184479","author":"K Miyabayashi","year":"2022","unstructured":"Miyabayashi K, Ijichi H, Fujishiro M. The role of the microbiome in pancreatic cancer. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14184479.","journal-title":"Cancers (Basel)"},{"key":"2988_CR66","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1136\/gutjnl-2021-324755","volume":"71","author":"E Kartal","year":"2022","unstructured":"Kartal E, Schmidt TSB, Molina-Montes E, Rodr\u00edguez-Perales S, Wirbel J, Maistrenko OM, et al. A faecal microbiota signature with high specificity for pancreatic cancer. Gut. 2022;71:1359\u201372. https:\/\/doi.org\/10.1136\/gutjnl-2021-324755.","journal-title":"Gut"},{"key":"2988_CR67","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1136\/gutjnl-2021-326710","volume":"71","author":"R Newsome","year":"2022","unstructured":"Newsome R, Jobin C. Finding clues in unexpected places: detection of pancreatic cancer through the faecal microbiome. Gut. 2022;71:1247\u20138. https:\/\/doi.org\/10.1136\/gutjnl-2021-326710.","journal-title":"Gut"},{"key":"2988_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104262","volume":"194","author":"X Guo","year":"2024","unstructured":"Guo X, Wang P, Li Y, Chang Y, Wang X. Microbiomes in pancreatic cancer can be an accomplice or a weapon. Crit Rev Oncol Hematol. 2024;194:104262. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104262.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2988_CR69","doi-asserted-by":"publisher","unstructured":"Ka\u017amierczak-Siedlecka K, Stachowska E, Folwarski M, Przew\u0142\u00f3cka K, Makarewicz W, Bryl E. The potential of gut microbiome as a non-invasive predictive biomarker for early detection of pancreatic cancer and hepatocellular carcinoma. Eur Rev Med Pharmacol Sci 2021;25:7275\u201384. https:\/\/doi.org\/10.26355\/eurrev_202112_27421.","DOI":"10.26355\/eurrev_202112_27421"},{"key":"2988_CR70","unstructured":"Rajpert-De Meyts E, Skakkebaek NE, Toppari J. Testicular cancer pathogenesis, diagnosis and endocrine aspects. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, et al., editors. Endotext, South Dartmouth (MA): MDText.com, Inc.; 2000."},{"key":"2988_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.727812","volume":"9","author":"S Wang","year":"2021","unstructured":"Wang S, Zhang K, Yao Y, Li J, Deng S. Bacterial infections affect male fertility: a focus on the oxidative stress-autophagy axis. Front Cell Dev Biol. 2021;9:727812. https:\/\/doi.org\/10.3389\/fcell.2021.727812.","journal-title":"Front Cell Dev Biol"},{"key":"2988_CR72","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4236\/ojpathology.2021.111002","volume":"11","author":"MM Al-Jebouri","year":"2021","unstructured":"Al-Jebouri MM, Mohamed AA. A study on infertility of males infected with Mycoplasma hominis with reference to sperm morphology. OJPathology. 2021;11:7\u201321. https:\/\/doi.org\/10.4236\/ojpathology.2021.111002.","journal-title":"OJPathology"},{"key":"2988_CR73","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftaa037","author":"S Saadat","year":"2020","unstructured":"Saadat S, Karami P, Jafari M, Kholoujini M, Rikhtegaran Tehrani Z, Mohammadi Y, et al. The silent presence of Mycoplasma hominis in patients with prostate cancer. Pathog Dis. 2020. https:\/\/doi.org\/10.1093\/femspd\/ftaa037.","journal-title":"Pathog Dis"},{"key":"2988_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1529871","volume":"14","author":"S Ciernikova","year":"2024","unstructured":"Ciernikova S, Sevcikova A, Mego M. Exploring the microbiome-gut-testis axis in testicular germ cell tumors. Front Cell Infect Microbiol. 2024;14:1529871. https:\/\/doi.org\/10.3389\/fcimb.2024.1529871.","journal-title":"Front Cell Infect Microbiol"},{"key":"2988_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13020315","author":"G Ece","year":"2025","unstructured":"Ece G, Akta\u015f A, Caner A, Sa\u011fl\u0131k \u0130, Kula Atik T, Ulusan Ba\u011fc\u0131 \u00d6, et al. The urogenital system microbiota: is it a new gamechanger in urogenital cancers? Microorganisms. 2025. https:\/\/doi.org\/10.3390\/microorganisms13020315.","journal-title":"Microorganisms"},{"key":"2988_CR76","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/andr.13305","volume":"11","author":"N M\u00f8rup","year":"2023","unstructured":"M\u00f8rup N, Main AM, J\u00f8rgensen N, Daugaard G, Juul A, Almstrup K. The seminal plasma microbiome of men with testicular germ cell tumours described by small RNA sequencing. Andrology. 2023;11:756\u201369. https:\/\/doi.org\/10.1111\/andr.13305.","journal-title":"Andrology"},{"key":"2988_CR77","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.eururo.2018.12.043","volume":"75","author":"MC Markowski","year":"2019","unstructured":"Markowski MC, Boorjian SA, Burton JP, Hahn NM, Ingersoll MA, Maleki Vareki S, et al. The microbiome and genitourinary cancer: a collaborative review. Eur Urol. 2019;75:637\u201346. https:\/\/doi.org\/10.1016\/j.eururo.2018.12.043.","journal-title":"Eur Urol"},{"key":"2988_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2022.119789","volume":"309","author":"S Wen","year":"2022","unstructured":"Wen S, Zhao Y, Liu S, Yuan H, You T, Xu H. Microplastics-perturbed gut microbiota triggered the testicular disorder in male mice: via fecal microbiota transplantation. Environ Pollut. 2022;309:119789. https:\/\/doi.org\/10.1016\/j.envpol.2022.119789.","journal-title":"Environ Pollut"},{"key":"2988_CR79","doi-asserted-by":"publisher","first-page":"04167","DOI":"10.7189\/jogh.13.04167","volume":"13","author":"C Guo","year":"2023","unstructured":"Guo C, Liu Z, Lin C, Fan H, Zhang X, Wang H, et al. Global epidemiology of early-onset liver cancer attributable to specific aetiologies and risk factors from 2010 to 2019. J Glob Health. 2023;13:04167. https:\/\/doi.org\/10.7189\/jogh.13.04167.","journal-title":"J Glob Health"},{"key":"2988_CR80","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/ijc.33313","volume":"148","author":"J-F Shi","year":"2021","unstructured":"Shi J-F, Cao M, Wang Y, Bai F-Z, Lei L, Peng J, et al. Is it possible to halve the incidence of liver cancer in China by 2050? Int J Cancer. 2021;148:1051\u201365. https:\/\/doi.org\/10.1002\/ijc.33313.","journal-title":"Int J Cancer"},{"key":"2988_CR81","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","volume":"70","author":"Z Liu","year":"2019","unstructured":"Liu Z, Jiang Y, Yuan H, Fang Q, Cai N, Suo C, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70:674\u201383. https:\/\/doi.org\/10.1016\/j.jhep.2018.12.001.","journal-title":"J Hepatol"},{"key":"2988_CR82","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1159\/000515304","volume":"10","author":"J Huang","year":"2021","unstructured":"Huang J, Lok V, Ngai CH, Chu C, Patel HK, Thoguluva Chandraseka V, et al. Disease burden, risk factors, and recent trends of liver cancer: a global country-level analysis. Liver Cancer. 2021;10:330\u201345. https:\/\/doi.org\/10.1159\/000515304.","journal-title":"Liver Cancer"},{"key":"2988_CR83","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1159\/000508568","volume":"9","author":"L Lin","year":"2020","unstructured":"Lin L, Yan L, Liu Y, Qu C, Ni J, Li H. The burden and trends of primary liver cancer caused by specific etiologies from 1990 to 2017 at the global, regional, national, age, and sex level results from the global burden of disease study 2017. Liver Cancer. 2020;9:563\u201382. https:\/\/doi.org\/10.1159\/000508568.","journal-title":"Liver Cancer"},{"key":"2988_CR84","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/hep4.1908","volume":"6","author":"D Qu","year":"2022","unstructured":"Qu D, Wang Y, Xia Q, Chang J, Jiang X, Zhang H. Intratumoral microbiome of human primary liver cancer. Hepatol Commun. 2022;6:1741\u201352. https:\/\/doi.org\/10.1002\/hep4.1908.","journal-title":"Hepatol Commun"},{"key":"2988_CR85","doi-asserted-by":"publisher","first-page":"26092","DOI":"10.1038\/s41598-024-77260-6","volume":"14","author":"HE Jo","year":"2024","unstructured":"Jo HE, Khom S, Lee S, Cho SH, Park SY, You GR, et al. Stage dependent microbial dynamics in hepatocellular carcinoma and adjacent normal liver tissues. Sci Rep. 2024;14:26092. https:\/\/doi.org\/10.1038\/s41598-024-77260-6.","journal-title":"Sci Rep"},{"key":"2988_CR86","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00983-22","volume":"10","author":"J-H Huang","year":"2022","unstructured":"Huang J-H, Wang J, Chai X-Q, Li Z-C, Jiang Y-H, Li J, et al. The intratumoral bacterial metataxonomic signature of hepatocellular carcinoma. Microbiol Spectr. 2022;10:e0098322. https:\/\/doi.org\/10.1128\/spectrum.00983-22.","journal-title":"Microbiol Spectr"},{"key":"2988_CR87","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","volume":"7","author":"TM Loo","year":"2017","unstructured":"Loo TM, Kamachi F, Watanabe Y, Yoshimoto S, Kanda H, Arai Y, et al. Gut microbiota promotes obesity-associated liver cancer through PGE2-mediated suppression of antitumor immunity. Cancer Discov. 2017;7:522\u201338. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0932.","journal-title":"Cancer Discov"},{"key":"2988_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/nu16142372","author":"M Pallozzi","year":"2024","unstructured":"Pallozzi M, De Gaetano V, Di Tommaso N, Cerrito L, Santopaolo F, Stella L, et al. Role of gut microbial metabolites in the pathogenesis of primary liver cancers. Nutrients. 2024. https:\/\/doi.org\/10.3390\/nu16142372.","journal-title":"Nutrients"},{"key":"2988_CR89","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/intimm\/dxac020","volume":"34","author":"T Kamiya","year":"2022","unstructured":"Kamiya T, Ohtani N. The role of immune cells in the liver tumor microenvironment: an involvement of gut microbiota-derived factors. Int Immunol. 2022;34:467\u201374. https:\/\/doi.org\/10.1093\/intimm\/dxac020.","journal-title":"Int Immunol"},{"key":"2988_CR90","doi-asserted-by":"publisher","first-page":"175883591984818","DOI":"10.1177\/1758835919848184","volume":"11","author":"FR Ponziani","year":"2019","unstructured":"Ponziani FR, Nicoletti A, Gasbarrini A, Pompili M. Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma. Ther Adv Med Oncol. 2019;11:1758835919848184. https:\/\/doi.org\/10.1177\/1758835919848184.","journal-title":"Ther Adv Med Oncol"},{"key":"2988_CR91","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28436","author":"A Kar","year":"2022","unstructured":"Kar A, Samanta A, Mukherjee S, Barik S, Biswas A. The HBV web: an insight into molecular interactomes between the Hepatitis B virus and its host en route to hepatocellular carcinoma. J Med Virol. 2022. https:\/\/doi.org\/10.1002\/jmv.28436.","journal-title":"J Med Virol"},{"key":"2988_CR92","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3350\/cmh.2024.0857","volume":"31","author":"C Li","year":"2025","unstructured":"Li C, Cai C, Wang C, Chen X, Zhang B, Huang Z. Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer. Clin Mol Hepatol. 2025;31:350\u201381. https:\/\/doi.org\/10.3350\/cmh.2024.0857.","journal-title":"Clin Mol Hepatol"},{"key":"2988_CR93","doi-asserted-by":"publisher","first-page":"11169","DOI":"10.1200\/JCO.2024.42.16_suppl.11169","volume":"42","author":"W-Z Li","year":"2024","unstructured":"Li W-Z, Gui X, Liang H, Wang W, Liang W, He J. Geographic and sociodemographic variations in disease burden, epidemiological trends, and risk factors of early-onset lung cancer: a global analysis. JCO. 2024;42:11169\u201311169. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.11169.","journal-title":"JCO"},{"key":"2988_CR94","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70639","volume":"14","author":"Z Li","year":"2025","unstructured":"Li Z, Yu C, Hao J, Luo N, Peng H, Zhang J, et al. Global trends of early, middle, and late-onset lung cancer from 1990 to 2021: results from the Global Burden of Disease Study 2021. Cancer Med. 2025;14:e70639. https:\/\/doi.org\/10.1002\/cam4.70639.","journal-title":"Cancer Med"},{"key":"2988_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104322","volume":"196","author":"W Liu","year":"2024","unstructured":"Liu W, Pi Z, Wang X, Shang C, Song C, Wang R, et al. Microbiome and lung cancer: carcinogenic mechanisms, early cancer diagnosis, and promising microbial therapies. Crit Rev Oncol Hematol. 2024;196:104322. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104322.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2988_CR96","doi-asserted-by":"publisher","first-page":"1492571","DOI":"10.3389\/fonc.2024.1492571","volume":"14","author":"X Zhai","year":"2024","unstructured":"Zhai X, Lin D, Shen Y, Zhai N, Yu F, Zhang J, et al. A novel interplay between bacteria and metabolites in different early-stage lung cancer: an integrated microbiome and metabolome analysis. Front Oncol. 2024;14:1492571. https:\/\/doi.org\/10.3389\/fonc.2024.1492571.","journal-title":"Front Oncol"},{"key":"2988_CR97","doi-asserted-by":"publisher","first-page":"1498524","DOI":"10.3389\/fonc.2024.1498524","volume":"14","author":"H-S Yang","year":"2024","unstructured":"Yang H-S, Zhang J, Feng H-X, Qi F, Kong F-J, Zhu W-J, et al. Characterizing microbial communities and their correlation with genetic mutations in early-stage lung adenocarcinoma: implications for disease progression and therapeutic targets. Front Oncol. 2024;14:1498524. https:\/\/doi.org\/10.3389\/fonc.2024.1498524.","journal-title":"Front Oncol"},{"key":"2988_CR98","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3934\/publichealth.2023044","volume":"10","author":"EK Drokow","year":"2023","unstructured":"Drokow EK, Effah CY, Agboyibor C, Budu JT, Arboh F, Kyei-Baffour PA, et al. Microbial infections as potential risk factors for lung cancer: investigating the role of human papillomavirus and chlamydia pneumoniae. AIMS Public Health. 2023;10:627\u201346. https:\/\/doi.org\/10.3934\/publichealth.2023044.","journal-title":"AIMS Public Health"},{"key":"2988_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1445113","author":"E Kameri","year":"2025","unstructured":"Kameri E, Jepsen VH, Stachura P, R\u00fcchel N, Bhave R, Benitez L, et al. A gut instinct for childhood leukemia prevention: microbiome-targeting recommendations aimed at parents and caregivers. Front Public Health. 2025. https:\/\/doi.org\/10.3389\/fpubh.2024.1445113.","journal-title":"Front Public Health"},{"key":"2988_CR100","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1182\/bloodadvances.2021005129","volume":"5","author":"R Masetti","year":"2021","unstructured":"Masetti R, Muratore E, Leardini D, Zama D, Turroni S, Brigidi P, et al. Gut microbiome in pediatric acute leukemia: from predisposition to cure. Blood Adv. 2021;5:4619\u201329. https:\/\/doi.org\/10.1182\/bloodadvances.2021005129.","journal-title":"Blood Adv"},{"key":"2988_CR101","doi-asserted-by":"publisher","first-page":"7244","DOI":"10.1182\/blood-2023-189071","volume":"142","author":"D Lan","year":"2023","unstructured":"Lan D, Xiong J-K, Zhang C, Zhang X. Association between gut microbiota and leukemia: a bidirectional multivariable Mendelian randomization study. Blood. 2023;142:7244\u20137244. https:\/\/doi.org\/10.1182\/blood-2023-189071.","journal-title":"Blood"},{"key":"2988_CR102","doi-asserted-by":"publisher","first-page":"1293333","DOI":"10.3389\/fmicb.2023.1293333","volume":"14","author":"G Chen","year":"2023","unstructured":"Chen G, Kuang Z, Li F, Li J. The causal relationship between gut microbiota and leukemia: a two-sample Mendelian randomization study. Front Microbiol. 2023;14:1293333. https:\/\/doi.org\/10.3389\/fmicb.2023.1293333.","journal-title":"Front Microbiol"},{"key":"2988_CR103","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood.2019004381","volume":"136","author":"C Vicente-Due\u00f1as","year":"2020","unstructured":"Vicente-Due\u00f1as C, Janssen S, Oldenburg M, Auer F, Gonz\u00e1lez-Herrero I, Casado-Garc\u00eda A, et al. An intact gut microbiome protects genetically predisposed mice against leukemia. Blood. 2020;136:2003\u201317. https:\/\/doi.org\/10.1182\/blood.2019004381.","journal-title":"Blood"},{"key":"2988_CR104","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284693","author":"T Faitova","year":"2024","unstructured":"Faitova T, Coelho M, Da Cunha-Bang C, Ozturk S, Kartal E, Bork P, et al. The diversity of the microbiome impacts chronic lymphocytic leukemia development in mice and humans. Haematologica. 2024. https:\/\/doi.org\/10.3324\/haematol.2023.284693.","journal-title":"Haematologica"},{"key":"2988_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2024.104211","author":"M Goswami","year":"2024","unstructured":"Goswami M, Bose PD. Gut microbial dysbiosis in the pathogenesis of leukemia: an immune-based perspective. Exp Hematol. 2024. https:\/\/doi.org\/10.1016\/j.exphem.2024.104211.","journal-title":"Exp Hematol"},{"key":"2988_CR106","doi-asserted-by":"publisher","unstructured":"Uribe-Herranz M, Klein-Gonz\u00e1lez N, Rodr\u00edguez-Lobato LG, Juan M, de Larrea CF. Gut microbiota influence in hematological malignancies: from genesis to cure. Int J Mol Sci 2021;22. https:\/\/doi.org\/10.3390\/ijms22031026.","DOI":"10.3390\/ijms22031026"},{"key":"2988_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910255","author":"P Guevara-Ram\u00edrez","year":"2024","unstructured":"Guevara-Ram\u00edrez P, Cadena-Ullauri S, Paz-Cruz E, Ruiz-Pozo VA, Tamayo-Trujillo R, Cabrera-Andrade A, et al. Gut microbiota disruption in hematologic cancer therapy: molecular insights and implications for treatment efficacy. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms251910255.","journal-title":"Int J Mol Sci"},{"key":"2988_CR108","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05480-3","author":"Y Xu","year":"2023","unstructured":"Xu Y, Gao H, Li H. The gut microbiome: an important factor influencing therapy for pediatric acute lymphoblastic leukemia. Ann Hematol. 2023. https:\/\/doi.org\/10.1007\/s00277-023-05480-3.","journal-title":"Ann Hematol"},{"key":"2988_CR109","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/cid\/ciy153","volume":"67","author":"H Hakim","year":"2018","unstructured":"Hakim H, Dallas R, Wolf J, Tang L, Schultz-Cherry S, Darling V, et al. Gut microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia. Clin Infect Dis. 2018;67:541\u20138. https:\/\/doi.org\/10.1093\/cid\/ciy153.","journal-title":"Clin Infect Dis"},{"key":"2988_CR110","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/cid\/ciz777","volume":"71","author":"JR Galloway-Pe\u00f1a","year":"2020","unstructured":"Galloway-Pe\u00f1a JR, Shi Y, Peterson CB, Sahasrabhojane P, Gopalakrishnan V, Brumlow CE, et al. Gut microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia. Clin Infect Dis. 2020;71:63\u201371. https:\/\/doi.org\/10.1093\/cid\/ciz777.","journal-title":"Clin Infect Dis"},{"key":"2988_CR111","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/children12020166","volume":"12","author":"SB Todor","year":"2025","unstructured":"Todor SB, Ichim C. Microbiome modulation in pediatric leukemia: impact on graft-versus-host disease and treatment outcomes: a narrative review. Children (Basel). 2025;12:166. https:\/\/doi.org\/10.3390\/children12020166.","journal-title":"Children (Basel)"},{"key":"2988_CR112","doi-asserted-by":"publisher","first-page":"1045497","DOI":"10.3389\/fmicb.2022.1045497","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Zhou C, Zhang A. Gut microbiota in acute leukemia: current evidence and future directions. Front Microbiol. 2022;13:1045497. https:\/\/doi.org\/10.3389\/fmicb.2022.1045497.","journal-title":"Front Microbiol"},{"key":"2988_CR113","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","volume":"20","author":"CC Wong","year":"2023","unstructured":"Wong CC, Yu J. Gut microbiota in colorectal cancer development and therapy. Nat Rev Clin Oncol. 2023;20:429\u201352. https:\/\/doi.org\/10.1038\/s41571-023-00766-x.","journal-title":"Nat Rev Clin Oncol"},{"key":"2988_CR114","doi-asserted-by":"publisher","first-page":"1208044","DOI":"10.3389\/fphar.2023.1208044","volume":"14","author":"AH Asseri","year":"2023","unstructured":"Asseri AH, Bakhsh T, Abuzahrah SS, Ali S, Rather IA. The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice. Front Pharmacol. 2023;14:1208044. https:\/\/doi.org\/10.3389\/fphar.2023.1208044.","journal-title":"Front Pharmacol"},{"key":"2988_CR115","doi-asserted-by":"publisher","unstructured":"Ting NL-N, Lau HC-H, Yu J. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes. Gut 2022;71:1412\u201325. https:\/\/doi.org\/10.1136\/gutjnl-2021-326264.","DOI":"10.1136\/gutjnl-2021-326264"},{"key":"2988_CR116","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13073-020-00796-5","volume":"12","author":"H Huang","year":"2020","unstructured":"Huang H, Ren Z, Gao X, Hu X, Zhou Y, Jiang J, et al. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma. Genome Med. 2020;12:102. https:\/\/doi.org\/10.1186\/s13073-020-00796-5.","journal-title":"Genome Med"},{"key":"2988_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217096","volume":"598","author":"X Li","year":"2024","unstructured":"Li X, Shang S, Wu M, Song Q, Chen D. Gut microbial metabolites in lung cancer development and immunotherapy: novel insights into gut-lung axis. Cancer Lett. 2024;598:217096. https:\/\/doi.org\/10.1016\/j.canlet.2024.217096.","journal-title":"Cancer Lett"},{"key":"2988_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1437869","author":"X Zhuang","year":"2024","unstructured":"Zhuang X, Yin Q, Yang R, Man X, Wang R, Geng H, et al. Causal pathways in lymphoid leukemia: the gut microbiota, immune cells, and serum metabolites. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1437869.","journal-title":"Front Immunol"},{"key":"2988_CR119","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s40487-024-00300-8","volume":"12","author":"Q Yang","year":"2024","unstructured":"Yang Q, Wang Z, Liu M, Gan L. Causal relationship between gut microbiota and leukemia: future perspectives. Oncol Ther. 2024;12:663\u201383. https:\/\/doi.org\/10.1007\/s40487-024-00300-8.","journal-title":"Oncol Ther"},{"key":"2988_CR120","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41568-023-00594-2","volume":"23","author":"G El Tekle","year":"2023","unstructured":"El Tekle G, Garrett WS. Bacteria in cancer initiation, promotion and progression. Nat Rev Cancer. 2023;23:600\u201318. https:\/\/doi.org\/10.1038\/s41568-023-00594-2.","journal-title":"Nat Rev Cancer"},{"key":"2988_CR121","doi-asserted-by":"publisher","first-page":"153303382513319","DOI":"10.1177\/15330338251331960","volume":"24","author":"K Xu","year":"2025","unstructured":"Xu K, Motiwala Z, Corona-Avila I, Makhanasa D, Alkahalifeh L, Khan MW. The gut microbiome and its multifaceted role in cancer metabolism, initiation, and progression: insights and therapeutic implications. Technol Cancer Res Treat. 2025;24:15330338251331960. https:\/\/doi.org\/10.1177\/15330338251331960.","journal-title":"Technol Cancer Res Treat"},{"key":"2988_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12010024","author":"S Ciernikova","year":"2023","unstructured":"Ciernikova S, Sevcikova A, Mladosievicova B, Mego M. Microbiome in cancer development and treatment. Microorganisms. 2023. https:\/\/doi.org\/10.3390\/microorganisms12010024.","journal-title":"Microorganisms"},{"key":"2988_CR123","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","volume":"39","author":"N Cullin","year":"2021","unstructured":"Cullin N, Azevedo Antunes C, Straussman R, Stein-Thoeringer CK, Elinav E. Microbiome and cancer. Cancer Cell. 2021;39:1317\u201341. https:\/\/doi.org\/10.1016\/j.ccell.2021.08.006.","journal-title":"Cancer Cell"},{"key":"2988_CR124","doi-asserted-by":"publisher","first-page":"1141215","DOI":"10.3389\/fcell.2023.1141215","volume":"11","author":"MP DiPalma","year":"2023","unstructured":"DiPalma MP, Blattman JN. The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME). Front Cell Dev Biol. 2023;11:1141215. https:\/\/doi.org\/10.3389\/fcell.2023.1141215.","journal-title":"Front Cell Dev Biol"},{"key":"2988_CR125","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/advances\/nmy076","volume":"10","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhang B, Dong L, Chang P. Potential of omega-3 polyunsaturated fatty acids in managing chemotherapy- or radiotherapy-related intestinal microbial dysbiosis. Adv Nutr. 2019;10:133\u201347. https:\/\/doi.org\/10.1093\/advances\/nmy076.","journal-title":"Adv Nutr"},{"key":"2988_CR126","first-page":"3508","volume":"10","author":"T Tian","year":"2020","unstructured":"Tian T, Zhao Y, Yang Y, Wang T, Jin S, Guo J, et al. The protective role of short-chain fatty acids acting as signal molecules in chemotherapy- or radiation-induced intestinal inflammation. Am J Cancer Res. 2020;10:3508\u201331.","journal-title":"Am J Cancer Res"},{"key":"2988_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175294","volume":"934","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li D, Sun L, Qi K, Shi L. Pharmacological inhibition of toll-like receptor 4 with TLR4-IN-C34 modulates the intestinal flora homeostasis and the MyD88\/NF-\u03baB axis in ulcerative colitis. Eur J Pharmacol. 2022;934:175294. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175294.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"2988_CR128","doi-asserted-by":"publisher","first-page":"856","DOI":"10.51248\/.v42i5.2275","volume":"42","author":"A Marathe","year":"2022","unstructured":"Marathe A, Rao GM, Rai S. Microbiota milieu and mechanisms of intestinal toll like receptors (TLRs) involved in chemotherapy induced mucositis. Biomedicine. 2022;42(5):856\u201362.","journal-title":"Biomedicine"},{"issue":"02","key":"2988_CR129","doi-asserted-by":"publisher","first-page":"903","DOI":"10.70749\/ijbr.v2i02.296","volume":"2","author":"AK Khalid","year":"2024","unstructured":"Khalid AK, Hafeez F, Qalandar S, Fatima H, Saqib M, Ali U, et al. Microbial biomarkers helpful in early detection of cancer: prognosis and suitable treatment. Indus J Bioscience Res. 2024;2(02):903\u201317.","journal-title":"Indus J Bioscience Res."},{"key":"2988_CR130","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.trecan.2023.08.001","volume":"9","author":"R Kataria","year":"2023","unstructured":"Kataria R, Shoaie S, Grigoriadis A, Wan JCM. Leveraging circulating microbial DNA for early cancer detection. Trends Cancer. 2023;9:879\u201382. https:\/\/doi.org\/10.1016\/j.trecan.2023.08.001.","journal-title":"Trends Cancer"},{"key":"2988_CR131","doi-asserted-by":"publisher","first-page":"101499","DOI":"10.1016\/j.xcrm.2024.101499","volume":"5","author":"H Chen","year":"2024","unstructured":"Chen H, Ma Y, Xu J, Wang W, Lu H, Quan C, et al. Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer. Cell Rep Med. 2024;5:101499. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101499.","journal-title":"Cell Rep Med"},{"key":"2988_CR132","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1002\/ijc.31011","volume":"141","author":"V Ekl\u00f6f","year":"2017","unstructured":"Ekl\u00f6f V, L\u00f6fgren-Burstr\u00f6m A, Zingmark C, Edin S, Larsson P, Karling P, et al. Cancer-associated fecal microbial markers in colorectal cancer detection. Int J Cancer. 2017;141:2528\u201336. https:\/\/doi.org\/10.1002\/ijc.31011.","journal-title":"Int J Cancer"},{"key":"2988_CR133","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.3748\/wjg.v24.i22.2327","volume":"24","author":"R Vill\u00e9ger","year":"2018","unstructured":"Vill\u00e9ger R, Lop\u00e8s A, Veziant J, Gagni\u00e8re J, Barnich N, Billard E, et al. Microbial markers in colorectal cancer detection and\/or prognosis. World J Gastroenterol. 2018;24:2327\u201347. https:\/\/doi.org\/10.3748\/wjg.v24.i22.2327.","journal-title":"World J Gastroenterol"},{"key":"2988_CR134","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1038\/s41467-021-23265-y","volume":"12","author":"Y Wu","year":"2021","unstructured":"Wu Y, Jiao N, Zhu R, Zhang Y, Wu D, Wang A-J, et al. Identification of microbial markers across populations in early detection of colorectal cancer. Nat Commun. 2021;12:3063. https:\/\/doi.org\/10.1038\/s41467-021-23265-y.","journal-title":"Nat Commun"},{"key":"2988_CR135","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1158\/1538-7445.AM2022-1184","volume":"82","author":"GD Sepich-Poore","year":"2022","unstructured":"Sepich-Poore GD, Fraraccio S, Wandro S, Knight R, Miller-Montgomery S, Adams E. Abstract 1184: Early-stage lung cancer detection via circulating microbial DNA biomarkers and machine learning classification. Cancer Res. 2022;82:1184\u20131184. https:\/\/doi.org\/10.1158\/1538-7445.AM2022-1184.","journal-title":"Cancer Res"},{"key":"2988_CR136","doi-asserted-by":"publisher","first-page":"100868","DOI":"10.1016\/j.neo.2022.100868","volume":"36","author":"FH Zwezerijnen-Jiwa","year":"2023","unstructured":"Zwezerijnen-Jiwa FH, Sivov H, Paizs P, Zafeiropoulou K, Kinross J. A systematic review of microbiome-derived biomarkers for early colorectal cancer detection. Neoplasia. 2023;36:100868. https:\/\/doi.org\/10.1016\/j.neo.2022.100868.","journal-title":"Neoplasia"},{"issue":"Suppl","key":"2988_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fasebj.2022.36.S1.R3041","volume":"36","author":"W Gao","year":"2022","unstructured":"Gao W, Sun R, Zhu L, Gao S, Feng Z, Wu D, et al. Microbial multidimensional signature assessment reveals microbial SNVs as the superior non-invasive biomarkers for early detection of colorectal cancer. FASEB J. 2022;36(Suppl):1. https:\/\/doi.org\/10.1096\/fasebj.2022.36.S1.R3041.","journal-title":"FASEB J"},{"issue":"15","key":"2988_CR138","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.3390\/cancers13153784","volume":"13","author":"M Stasiewicz","year":"2021","unstructured":"Stasiewicz M, Kwa\u015bniewski M, Karpi\u0144ski TM. Microbial associations with pancreatic cancer: a new frontier in biomarkers. Cancers. 2021;13(15):3784. https:\/\/doi.org\/10.3390\/cancers13153784.","journal-title":"Cancers"},{"key":"2988_CR139","doi-asserted-by":"publisher","first-page":"1184869","DOI":"10.3389\/fmicb.2023.1184869","volume":"14","author":"J Yang","year":"2023","unstructured":"Yang J, Ma Y, Tan Q, Zhou B, Yu D, Jin M, et al. Gut Streptococcus is a microbial marker for the occurrence and liver metastasis of pancreatic cancer. Front Microbiol. 2023;14:1184869. https:\/\/doi.org\/10.3389\/fmicb.2023.1184869.","journal-title":"Front Microbiol"},{"key":"2988_CR140","doi-asserted-by":"publisher","first-page":"16801","DOI":"10.1038\/s41598-019-53041-4","volume":"9","author":"E Half","year":"2019","unstructured":"Half E, Keren N, Reshef L, Dorfman T, Lachter I, Kluger Y, et al. Fecal microbiome signatures of pancreatic cancer patients. Sci Rep. 2019;9:16801. https:\/\/doi.org\/10.1038\/s41598-019-53041-4.","journal-title":"Sci Rep"},{"key":"2988_CR141","doi-asserted-by":"publisher","first-page":"e1726","DOI":"10.1002\/ctm2.1726","volume":"14","author":"W Wang","year":"2024","unstructured":"Wang W, Qian C, Wang T, Jiang Y, Zhou Y, Liu K, et al. A combination of faecal and intratumour microbial community profiling reveals novel diagnostic and prognostic biomarkers for pancreatic tumours. Clin Transl Med. 2024;14:e1726. https:\/\/doi.org\/10.1002\/ctm2.1726.","journal-title":"Clin Transl Med"},{"key":"2988_CR142","doi-asserted-by":"publisher","unstructured":"Leng Q, Holden VK, Deepak J, Todd NW, Jiang F. Microbiota biomarkers for lung cancer. Diagnostics (Basel) 2021;11. https:\/\/doi.org\/10.3390\/diagnostics11030407.","DOI":"10.3390\/diagnostics11030407"},{"key":"2988_CR143","doi-asserted-by":"publisher","first-page":"e0074723","DOI":"10.1128\/msystems.00747-23","volume":"8","author":"J Chen","year":"2023","unstructured":"Chen J, Nie S, Qiu X, Zheng S, Ni C, Yuan Y, et al. Leveraging existing 16S rRNA microbial data to identify diagnostic biomarker in Chinese patients with gastric cancer: a systematic meta-analysis. MSystems. 2023;8:e0074723. https:\/\/doi.org\/10.1128\/msystems.00747-23.","journal-title":"MSystems"},{"key":"2988_CR144","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2095-1","volume":"579","author":"GD Poore","year":"2020","unstructured":"Poore GD, Kopylova E, Zhu Q, Carpenter C, Fraraccio S, Wandro S, et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature. 2020;579:567\u201374. https:\/\/doi.org\/10.1038\/s41586-020-2095-1.","journal-title":"Nature"},{"key":"2988_CR145","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2021.08.036","volume":"521","author":"H Chen","year":"2021","unstructured":"Chen H, Ma Y, Liu Z, Li J, Li X, Yang F, et al. Circulating microbiome DNA: an emerging paradigm for cancer liquid biopsy. Cancer Lett. 2021;521:82\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2021.08.036.","journal-title":"Cancer Lett"},{"issue":"1","key":"2988_CR146","doi-asserted-by":"publisher","first-page":"13974","DOI":"10.1038\/s41598-018-32413-2","volume":"8","author":"M Mangifesta","year":"2018","unstructured":"Mangifesta M, Mancabelli L, Milani C, Gaiani F, de Angelis N, de Angelis GL, et al. Mucosal microbiota of intestinal polyps reveals putative biomarkers of colorectal cancer. Sci rep. 2018;8(1):13974. https:\/\/doi.org\/10.1038\/s41598-018-32413-2.","journal-title":"Sci rep"},{"key":"2988_CR147","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1136\/gutjnl-2016-313189","volume":"67","author":"MS Shah","year":"2018","unstructured":"Shah MS, DeSantis TZ, Weinmaier T, McMurdie PJ, Cope JL, Altrichter A, et al. Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer. Gut. 2018;67:882\u201391. https:\/\/doi.org\/10.1136\/gutjnl-2016-313189.","journal-title":"Gut"},{"key":"2988_CR148","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/procel\/pwad052","volume":"15","author":"J-H Dai","year":"2024","unstructured":"Dai J-H, Tan X-R, Qiao H, Liu N. Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets. Protein Cell. 2024;15:239\u201360. https:\/\/doi.org\/10.1093\/procel\/pwad052.","journal-title":"Protein Cell"},{"issue":"8","key":"2988_CR149","doi-asserted-by":"publisher","first-page":"001744","DOI":"10.1099\/jmm.0.001744","volume":"72","author":"X Li","year":"2023","unstructured":"Li X, Yuan X, Zhu X, Li C, Ji L, Lv K, et al. A meta-analysis of tissue microbial biomarkers for recurrence and metastasis in multiple cancer types. J Med Microbiol. 2023;72(8):001744. https:\/\/doi.org\/10.1099\/jmm.0.001744.","journal-title":"J Med Microbiol"},{"key":"2988_CR150","doi-asserted-by":"publisher","first-page":"115332","DOI":"10.1016\/j.addr.2024.115332","volume":"210","author":"YS Cho","year":"2024","unstructured":"Cho YS, Han K, Xu J, Moon JJ. Novel strategies for modulating the gut microbiome for cancer therapy. Adv Drug Deliv Rev. 2024;210:115332. https:\/\/doi.org\/10.1016\/j.addr.2024.115332.","journal-title":"Adv Drug Deliv Rev"},{"key":"2988_CR151","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/10408363.2019.1660303","volume":"56","author":"DJ Schwartz","year":"2019","unstructured":"Schwartz DJ, Rebeck ON, Dantas G. Complex interactions between the microbiome and cancer immune therapy. Crit Rev Clin Lab Sci. 2019;56:567\u201385. https:\/\/doi.org\/10.1080\/10408363.2019.1660303.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2988_CR152","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1038\/s41388-020-1341-1","volume":"39","author":"W Fong","year":"2020","unstructured":"Fong W, Li Q, Yu J. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer. Oncogene. 2020;39:4925\u201343. https:\/\/doi.org\/10.1038\/s41388-020-1341-1.","journal-title":"Oncogene"},{"key":"2988_CR153","doi-asserted-by":"publisher","first-page":"127668","DOI":"10.1016\/j.micres.2024.127668","volume":"282","author":"W Wang","year":"2024","unstructured":"Wang W, Fan J, Zhang C, Huang Y, Chen Y, Fu S, et al. Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses. Microbiol Res. 2024;282:127668. https:\/\/doi.org\/10.1016\/j.micres.2024.127668.","journal-title":"Microbiol Res"},{"key":"2988_CR154","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.semcancer.2020.06.009","volume":"70","author":"N Sehrawat","year":"2021","unstructured":"Sehrawat N, Yadav M, Singh M, Kumar V, Sharma VR, Sharma AK. Probiotics in microbiome ecological balance providing a therapeutic window against cancer. Semin Cancer Biol. 2021;70:24\u201336. https:\/\/doi.org\/10.1016\/j.semcancer.2020.06.009.","journal-title":"Semin Cancer Biol"},{"key":"2988_CR155","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jbiotec.2024.07.002","volume":"392","author":"Z R\u00e9thi-Nagy","year":"2024","unstructured":"R\u00e9thi-Nagy Z, Juh\u00e1sz S. Microbiome\u2019s Universe: Impact on health, disease and cancer treatment. J Biotechnol. 2024;392:161\u201379. https:\/\/doi.org\/10.1016\/j.jbiotec.2024.07.002.","journal-title":"J Biotechnol"},{"key":"2988_CR156","doi-asserted-by":"crossref","unstructured":"Quigley EMM, Gajula P. Recent advances in modulating the microbiome. [version 1; peer review: 2 approved]. F1000Res 2020;9.","DOI":"10.12688\/f1000research.20204.1"},{"key":"2988_CR157","doi-asserted-by":"publisher","first-page":"1412709","DOI":"10.3389\/fmed.2024.1412709","volume":"11","author":"A Marashi","year":"2024","unstructured":"Marashi A, Hasany S, Moghimi S, Kiani R, Mehran Asl S, Dareghlou YA, et al. Targeting gut-microbiota for gastric cancer treatment: a systematic review. Front Med (Lausanne). 2024;11:1412709. https:\/\/doi.org\/10.3389\/fmed.2024.1412709.","journal-title":"Front Med (Lausanne)"},{"key":"2988_CR158","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41568-022-00513-x","volume":"22","author":"MR Fernandes","year":"2022","unstructured":"Fernandes MR, Aggarwal P, Costa RGF, Cole AM, Trinchieri G. Targeting the gut microbiota for cancer therapy. Nat Rev Cancer. 2022;22:703\u201322. https:\/\/doi.org\/10.1038\/s41568-022-00513-x.","journal-title":"Nat Rev Cancer"},{"key":"2988_CR159","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11427-023-2634-7","volume":"68","author":"S-S Jiang","year":"2025","unstructured":"Jiang S-S, Kang Z-R, Chen Y-X, Fang J-Y. The gut microbiome modulate response to immunotherapy in cancer. Sci China Life Sci. 2025;68:381\u201396. https:\/\/doi.org\/10.1007\/s11427-023-2634-7.","journal-title":"Sci China Life Sci"},{"key":"2988_CR160","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40425-019-0574-4","volume":"7","author":"J Fessler","year":"2019","unstructured":"Fessler J, Matson V, Gajewski TF. Exploring the emerging role of the microbiome in cancer immunotherapy. J Immunother Cancer. 2019;7:108. https:\/\/doi.org\/10.1186\/s40425-019-0574-4.","journal-title":"J Immunother Cancer"},{"key":"2988_CR161","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41565-019-0589-5","volume":"14","author":"W Song","year":"2019","unstructured":"Song W, Anselmo AC, Huang L. Nanotechnology intervention of the microbiome for cancer therapy. Nat Nanotechnol. 2019;14:1093\u2013103. https:\/\/doi.org\/10.1038\/s41565-019-0589-5.","journal-title":"Nat Nanotechnol"},{"key":"2988_CR162","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/jncimonographs\/lgz026","volume":"2019","author":"R Bhuta","year":"2019","unstructured":"Bhuta R, Nieder M, Jubelirer T, Ladas EJ. The gut microbiome and pediatric cancer: current research and gaps in knowledge. J Natl Cancer Inst Monographs. 2019;2019:169\u201373. https:\/\/doi.org\/10.1093\/jncimonographs\/lgz026.","journal-title":"J Natl Cancer Inst Monographs"},{"key":"2988_CR163","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1158\/2159-8290.CD-21-0324","volume":"11","author":"RJ Knippel","year":"2021","unstructured":"Knippel RJ, Drewes JL, Sears CL. The cancer microbiome: recent highlights and knowledge gaps. Cancer Discov. 2021;11:2378\u201395. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0324.","journal-title":"Cancer Discov"},{"key":"2988_CR164","doi-asserted-by":"publisher","first-page":"1490007","DOI":"10.3389\/fmicb.2024.1490007","volume":"15","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Jiang M, Li X, Shen K, Zong H, Lv Q, et al. Bibliometric and visual analysis of human microbiome-breast cancer interactions: current insights and future directions. Front Microbiol. 2024;15:1490007. https:\/\/doi.org\/10.3389\/fmicb.2024.1490007.","journal-title":"Front Microbiol"},{"key":"2988_CR165","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s10238-024-01523-9","volume":"25","author":"HH Qasem","year":"2024","unstructured":"Qasem HH, El-Sayed WM. The bacterial microbiome and cancer: development, diagnosis, treatment, and future directions. Clin Exp Med. 2024;25:12. https:\/\/doi.org\/10.1007\/s10238-024-01523-9.","journal-title":"Clin Exp Med"},{"issue":"18","key":"2988_CR166","doi-asserted-by":"publisher","first-page":"13786","DOI":"10.3390\/ijms241813786","volume":"24","author":"L Aitmanait\u0117","year":"2023","unstructured":"Aitmanait\u0117 L, \u0160irmonaitis K, Russo G. Microbiomes, their function, and cancer: how metatranscriptomics can close the knowledge gap. Int j mol sci. 2023;24(18):13786. https:\/\/doi.org\/10.3390\/ijms241813786.","journal-title":"Int j mol sci"},{"key":"2988_CR167","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41568-019-0155-3","volume":"19","author":"E Elinav","year":"2019","unstructured":"Elinav E, Garrett WS, Trinchieri G, Wargo J. The cancer microbiome. Nat Rev Cancer. 2019;19:371\u20136. https:\/\/doi.org\/10.1038\/s41568-019-0155-3.","journal-title":"Nat Rev Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02988-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02988-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02988-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T07:16:29Z","timestamp":1758093389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02988-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,6]]},"references-count":167,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["2988"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02988-8","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,6]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"464"}}